// App-Quantinova.ai

TCT-646 : Primary Results Following Percutaneous Coronary Intervention with the 38 mm Resolute Zotarolimus-eluting Stent

Researchers

Presenter

  • Shirish Hiremath

Principal Investigators

  • Robaayah Zambahari

  • Martin Leon

  • Laura Mauri

  • Alan Yeung

  • Michael Lee

Medical Centers

  • Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, United States

  • Ruby Hall Clinic, Pune, India

  • Queen Elizebeth Hospital, Hong Kong, Hong Kong

Locations

  • United States

  • India

  • Malaysia

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary artery lesions

  • Multi-vessel disease

  • Diabetes

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved